Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy

Journal of Gastroenterology

Volumn 38, Issue 4, 2003, Pages 395-398

  Tomimatsu, Masahiko ^a   Endo, Hitoshi ^a   Kitazawa, Misa ^a   Iga, Daijiro ^a   Fujimoto, Tomoko ^a   Ohkawa, Shin Ichiro ^a   Kajiyama, Hideki ^a   Katagiri, Satoshi ^a   Harada, Nobuhiko ^a   Yamamoto, Masakazu ^a   Takasaki, Ken ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis; Hepatitis C virus; Hepatocellular carcinoma; Interferon

Indexed keywords

HEPATITIS C ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; ILEUS; IMAGE ANALYSIS; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 0037852920     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300070     Document Type: Article

References (15)

1. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993;72:683-8.
2. Tsubota A, Chayama A, Ikeda K, Arase Y, Koida I, Saitoh S, et al. Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 1994;19:1088-94.
3. Ikeda K, Saitoh S, Arase Y, Chayama A, Suzuki Y, Kobayashi M, et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999;29:1124-30.
4. Sugiura N, Sakai Y, Ebara M, Fukuda H, Yoshikawa M, Saisho H, et al. Detection of hepatocellular carcinoma after interferon therapy for chronic hepatitis C: clinical study of 26 cases. J Gastroenterol Hepatol 1996;11:535-9.
5. Ichida F, Tsuji F, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-9.
6. Tarao K, Takemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, et al. Relation between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 1997;79:688-94.
7. Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. J Hepatol 1999;30:653-9.
8. Kasahara A, Hayashi N, Mochizuku K, Takayanagi M, Yoshioka K, Kakumu S, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998;27:1394-402.
9. Tamori A, Kuroki T, Nishiguchi S, Morimoto H, Morimoto M, Hirohashi K, et al. Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus. Hepatogastroenterology 1996;43:1079-83.
10. Hirashima N, Mizokami M, Orito E, Koide T, Itazu I, Kumada K, et al. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to interferon-α. J Gastroenterol Hepatol 1996;11:955-8.
11. Yamaguchi K, Omagari K, Kinoshita H, Yoshioka S, Furusu H, Takeshima F, et al. Development of hepatocellular carcinoma in a patient with chronic hepatitis C after 6 years of a sustained and complete response to IFN-α. J Clin Gastroenterol 1999;29: 207-9.
12. Majima Y. Growth rate of hepatocellular carcinoma by ultrasonography and it's clinical significance (in Japanese with English abstract). Acta Hepatol Jpn 1984;25:754-65.
13. Tomimatsu M, Endou H, Takahashi H, Iga D, Kato Y, Tamai N, et al. Negative strand of hepatitis C virus RNA in the liver of patients with chronic hepatitis after interferon treatment. J Gastroenterol Hepatol 1997;12:629-32.
14. Chang J, Yang S-H, Cho Y-G, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 1998;72:3060-5.
15. Hashizume K, Yotsuyanagi H, Suzuki M. Association of hepatitis B virus DNA in non-B, non-C hepatocellular carcinoma (in Japanese with English abstract). Acta Hepatol Jpn 1999;40:395-403.